Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
NCT00185042 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 534
Last updated 2007-09-11
Summary
The purpose of this study is to learn if CS-505 is safe and effective for slowing down or possibly reversing the buildup of tissue, cells and fatty deposits (plaque) in the blood vessels of the heart (coronary artery atherosclerosis).
Conditions
Interventions
- DRUG
-
Pactimibe, CS-505
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-11-30
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
NCT00384293 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease
NCT00312052 ·Status: COMPLETED ·Phase: PHASE2
-
Revacept in Symptomatic Carotid Stenosis
NCT01645306 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
NCT07301034 ·Status: RECRUITING ·Phase: PHASE3
-
Atherosclerosis in the Coronary and Carotid Arteries
NCT00080587 ·Status: COMPLETED
-
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
NCT06586684 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
NCT01327846 ·Status: COMPLETED ·Phase: PHASE3
-
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
NCT00124332 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome
NCT00619164 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
NCT00995930 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
NCT03872401 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
NCT01975389 ·Status: TERMINATED ·Phase: PHASE3
-
The Changes in Carotid Plaque Neovascularization After Elovocumab Therapy
NCT04423406 ·Status: UNKNOWN
-
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
NCT05030428 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
NCT07050134 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis
NCT02049203 ·Status: COMPLETED ·Phase: PHASE1
-
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
NCT00695305 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
NCT04338165 ·Status: UNKNOWN ·Phase: PHASE2
-
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
NCT05360446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
NCT03254446 ·Status: UNKNOWN ·Phase: PHASE3
-
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
NCT00307307 ·Status: COMPLETED ·Phase: PHASE4
-
Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB
NCT03469349 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
NCT00155350 ·Status: UNKNOWN ·Phase: PHASE4
-
PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population
NCT05043740 ·Status: UNKNOWN ·Phase: NA